Related Experiment Video
Updated: May 31, 2025
06:03
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
1.2K
Decoding NAD+ Metabolism in COVID-19: Implications for Immune Modulation and Therapy
Shixu Song1,2, Jialing Gan1,2, Qiuyue Long1,2
1Department of Respiratory, Critical Care and Sleep Medicine, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361101, China.
Vaccines
|January 24, 2025
Summary
Investigating nicotinamide adenine dinucleotide (NAD+) metabolism in COVID-19 reveals potential therapeutic targets. Modulating NAD+ pathways may enhance immune defense against SARS-CoV-2, offering new treatment avenues.
Area of Science:
- Biochemistry
- Immunology
- Virology
Background:
- COVID-19 presents an ongoing global health challenge, with limited therapeutic options beyond antivirals.
- Current immunotherapies show suboptimal efficacy against SARS-CoV-2 and its variants.
- NAD+ metabolism is dysregulated in COVID-19, with decreased NAD+ levels and increased consumption by enzymes like CD38 and PARPs.
Purpose of the Study:
- To review the role of NAD+ metabolism in COVID-19 pathogenesis.
- To explore the therapeutic potential of modulating NAD+ homeostasis for COVID-19 treatment.
- To identify strategies for targeting NAD+ pathways to enhance host immunity.
Main Methods:
- Literature review focusing on NAD+ metabolism and its connection to COVID-19.
- Analysis of scientific literature on immunotherapies and their limitations.
- Examination of proposed therapeutic strategies involving NAD+ precursors and enzyme inhibitors.
Main Results:
- NAD+ plays a critical role in cellular energy metabolism and immune function.
- Decreased NAD+ levels and increased consumption are observed in COVID-19 patients.
- Targeting NAD+ pathways offers a promising, novel therapeutic strategy.
Conclusions:
- Modulating NAD+ homeostasis may significantly enhance the host's immune response to COVID-19.
- NAD+ precursor supplementation and enzyme inhibition are potential therapeutic interventions.
- Further research is crucial to optimize NAD+ therapies for clinical application and other infectious diseases.
